US Patent No: 8,142,811

Number of patents in Portfolio can not be more than 2000

Controlled release hydrocodone formulations

2 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PURDUE PHARMA L.P.STAMFORD, CT380

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Hua-Pin Englewood Cliffs, US 54 1916
Masselink, John K Old Tappan, US 24 545
Oshlack, Benjamin New York, US 215 10024
Tonelli, Alfred P Congers, US 15 658

Cited Art Landscape

Patent Info (Count) # Cites Year
 
RIJKSUNIVERSITEIT GRONINGEN (1)
4,708,874 Devices for the controlled release of active substances, as well as process for the preparation thereof 73 1986
 
PHARMACIA & UPJOHN AB (1)
5,614,218 Controlled release preparation 58 1994
 
ELAN CORPORATION, PLC (2)
4,609,542 New pharmaceutical forms for administration of medicaments by oral route, with programmed release 47 1985
5,637,320 Controlled absorption naproxen formulation for once-daily administration 61 1994
 
NIRO HOLDING A/S (1)
5,030,400 Process and an apparatus for agglomeration of a powdery material 79 1990
 
VIRGINIA COMMONWEALTH UNIVERSITY (2)
5,321,012 Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance 171 1993
5,502,058 Method for the treatment of pain 151 1994
 
PFIZER INC. (1)
4,861,596 Rolled matrix device having enhanced ability to unroll and method for its production 25 1988
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5,026,560 Spherical granules having core and their production 163 1988
 
NIPPON SHINYAKU CO., LTD. (1)
5,456,923 Method of manufacturing solid dispersion 156 1993
 
Hoechst Aktiengesellschaft (1)
4,935,246 Process for the coating of granules 122 1988
 
CIBA-GEIGY CORPORATION (1)
4,548,990 Crosslinked, porous polymers for controlled drug delivery 133 1983
 
GRUENENTHAL GMBH (1)
5,601,842 Sustained release drug formulation containing a tramadol salt 75 1996
 
MERCK SHARP & DOHME CORP. (1)
4,377,568 Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same 74 1981
 
RHODIA INC. (2)
6,264,983 Directly compressible, ultra fine acetaminophen compositions and process for producing same 28 1999
6,607,750 Directly compressible acetaminophen compositions 31 2001
 
Warner-Lambert Company (4)
4,483,847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 85 1983
4,600,645 Process for treating dosage forms 73 1985
5,068,110 Stabilization of enteric coated dosage form 75 1989
5,167,964 Semi-enteric drug delivery systems and methods for preparing same 88 1992
 
FOREST LABORATORIES, INC. (1)
4,389,393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 295 1982
 
FISONS CORPORATION (1)
4,959,219 Coating barriers comprising ethyl cellulose 45 1988
 
ROHM GMBH (1)
4,520,172 Method for coating medicaments 57 1983
 
AMERICAN CYANAMID COMPANY (1)
5,283,065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 104 1992
 
MERIAL (1)
5,958,425 Viral vaccines 3 1997
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5,169,645 Directly compressible granules having improved flow properties 142 1989
 
ZYMA SA (1)
4,728,513 Granular delayed-release form of pharmaceutically active substances 80 1986
 
Duphar International Research B.V. (1)
5,219,575 Compositions with controlled zero-order delivery rate and method of preparing these compositions 37 1990
 
DEUTSCHE BANK AG NEW YORK BRANCH (1)
4,983,730 Water soluble cellulose acetate composition having improved processability and tensile properties 77 1988
 
RICHARDSON-VICKS INC. (1)
4,996,047 Sustained release drug-resin complexes 109 1988
 
ALZA CORPORATION (7)
5,019,397 Aqueous emulsion for pharmaceutical dosage form 102 1988
5,024,842 Annealed coats 91 1990
5,460,826 Morphine therapy 131 1994
6,491,945 Hydrocodone therapy 54 1994
5,593,695 Morphine therapy 68 1995
* 5,866,161 Hydrocodone therapy 67 1996
5,667,805 Morphine therapy 59 1996
 
VALEANT INTERNATIONAL BERMUDA (1)
5,518,730 Biodegradable controlled release flash flow melt-spun delivery system 221 1992
 
MERRELL DOW PHARMACEUTICALS INC. (1)
4,421,736 Sustained release diethylpropion compositions 75 1982
 
EURO-CELTIQUE S.A. (12)
4,443,428 Extended action controlled release compositions 132 1982
4,844,907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 149 1986
5,071,646 Pharmaceutical ion exchange resin composition 143 1989
5,356,467 Controlled release coatings derived from aqueous dispersions of zein 205 1993
5,500,227 Immediate release tablet cores of insoluble drugs having sustained-release coating 186 1993
5,670,172 Pharmaceutical spheroid formulation 97 1995
5,849,240 Method of preparing sustained release pharmaceutical compositions 165 1996
5,891,471 Pharmaceutical multiparticulates 144 1996
5,843,480 Controlled release diamorphine formulation 116 1996
5,879,705 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions 152 1997
5,965,163 Substained release compositions and a method of preparing pharmaceutical compositions 155 1997
6,572,885 Orally administrable opioid formulations having extended duration of effect 94 2001
 
PURDUE PHARMA L.P. (25)
4,828,836 Controlled release pharmaceutical composition 217 1987
4,834,985 Controlled release pharmaceutical composition 229 1987
4,990,341 Controlled release hydromorphone composition 168 1989
5,266,331 Controlled release oxycodone compositions 234 1991
5,273,760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 246 1991
5,286,493 Stabilized controlled release formulations having acrylic polymer coating 242 1992
5,549,912 Controlled release oxycodone compositions 227 1993
5,472,712 Controlled-release formulations coated with aqueous dispersions of ethylcellulose 229 1993
5,580,578 Controlled release formulations coated with aqueous dispersions of acrylic polymers 210 1993
5,478,577 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level 238 1993
5,411,745 Powder-layered morphine sulfate formulations 148 1994
5,965,161 Extruded multi-particulates 178 1994
5,639,476 Controlled release formulations coated with aqueous dispersions of acrylic polymers 504 1995
5,508,042 Controlled release oxycodone compositions 247 1995
5,968,551 Orally administrable opioid formulations having extended duration of effect 246 1995
5,958,459 Opioid formulations having extended controlled released 160 1995
5,656,295 Controlled release oxycodone compositions 212 1996
5,681,585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 136 1996
5,672,360 Method of treating pain by administering 24 hour oral opioid formulations 225 1996
6,143,322 Method of treating humans with opioid formulations having extended controlled release 162 1997
5,958,452 Extruded orally administrable opioid formulations 211 1997
6,103,261 Opioid formulations having extended controlled release 157 1999
6,294,195 Orally administrable opioid formulations having extended duration of effect 148 1999
6,733,783 Controlled release hydrocodone formulations 149 2001
2004/0266,807 Controlled release hydrocodone formulations 58 2004
 
ASAHI KASEI CHEMICALS CORPORATION (1)
5,384,130 Spherical seed cores, spherical granules and process for production thereof 59 1993
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4,844,909 Controlled release hydromorphone composition 160 1987
 
ALPHARMA PHARMACEUTICALS, LLC (3)
5,202,128 Sustained release pharmaceutical composition 177 1990
5,330,766 Sustained release pharmaceutical composition 145 1993
5,378,474 Sustained release pharmaceutical composition 151 1993
 
University of Kentucky Research Foundation (1)
4,464,378 Method of administering narcotic antagonists and analgesics and novel dosage forms containing same 206 1981
 
ARCHIMEDES DEVELOPMENT LIMITED (1)
5,629,011 Composition for nasal administration 90 1994
 
MILES INC. (1)
4,797,410 Suppression of withdrawal symptoms in opioid-induced tolerance or dependence 47 1987
 
DRUGTECH CORPORATION (2)
5,122,384 Oral once-per-day organic nitrate formulation which does not induce tolerance 48 1989
5,133,974 Extended release pharmaceutical formulations 300 1990
 
FMC CORPORATION (3)
5,206,030 Film-forming composition and use for coating pharmaceuticals, foods and the like 61 1990
5,248,516 Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like 49 1991
5,258,436 Film-forming composition; method of producing same and use for coating pharmaceuticals and foods and the like 39 1991
 
DepoMed Systems, Inc. (1)
5,007,790 Sustained-release oral drug dosage form 179 1989
 
UCB PHARMA S.A. (1)
6,699,502 Pharmaceutical compositions for controlled release of active substances 52 1999
 
GLATT GMBH (1)
5,132,142 Apparatus and method for producing pellets by layering power onto particles 67 1991
 
GACELL LABORATORIES AB (3)
4,557,925 Membrane-coated sustained-release tablets and method 117 1984
5,178,868 Dosage form 70 1991
5,520,931 Controlled release morphine preparation 61 1995
 
CADBURY ADAMS USA LLC (1)
4,894,234 Novel drug delivery system for antiarrhythmics 88 1988
 
PURDUE PHARMA COMPANY, THE (2)
4,861,598 Controlled release bases for pharmaceuticals 215 1986
4,970,075 Controlled release bases for pharmaceuticals 182 1989
 
WATSON LABORATORIES, INC. (1)
4,806,337 Erodible matrix for sustained release bioactive composition 144 1986
 
SPRING AG, PHARMAZEUTISCHE PRAEPARATE A SWISS CORP. (1)
5,292,461 Process for the production of pellets 72 1991
 
F.H. FAULDING & CO. LIMITED (1)
5,196,203 Theophylline dosage form 57 1991
 
PUREUE PHARMA L.P. (1)
4,834,984 Controlled release dihydrocodeine composition 153 1987
 
Shionogi & Co., Ltd. (1)
5,023,089 Sustained-release preparations and the process thereof 64 1989
 
TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 125 1990
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
OPKO RENAL, LLC (2)
9,408,858 Method for treating secondary hyperparathyroidism in CKD 0 2015
9,498,486 Method for controlled release oral dosage of a vitamin D compound 0 2016
 
PURDUE PHARMA L.P. (16)
8,980,291 Controlled release hydrocodone formulations 3 2010
* 8,551,520 Controlled release hydrocodone 19 2012
8,975,271 Controlled release hydrocodone formulations 0 2013
* 9,060,940 Controlled release hydrocodone 3 2014
8,975,273 Controlled release hydrocodone formulations 1 2014
8,951,555 Controlled release hydrocodone formulations 6 2014
9,023,401 Controlled release hydrocodone formulations 7 2014
9,056,052 Controlled release hydrocodone formulations 6 2015
9,056,107 Controlled release hydrocodone formulations 0 2015
9,320,717 Controlled release hydrocodone formulations 0 2015
9,278,074 Controlled release hydrocodone formulations 0 2015
9,289,391 Controlled release hydrocodone formulations 1 2015
9,205,055 Controlled release hydrocodone formulations 1 2015
9,205,056 Controlled release hydrocodone formulations 1 2015
9,198,863 Controlled release hydrocodone formulations 1 2015
9,504,681 Controlled release hydrocodone formulations 0 2016
 
EGALET LTD. (7)
8,877,241 Morphine controlled release system 2 2004
9,005,660 Immediate release composition resistant to abuse by intake of alcohol 2 2010
9,023,394 Formulations and methods for the controlled release of active drug substances 1 2013
8,808,745 Morphine polymer release system 5 2013
9,044,402 Abuse-deterrent pharmaceutical compositions for controlled release 1 2014
9,375,428 Morphine controlled release system 0 2014
9,358,295 Immediate release composition resistant to abuse by intake of alcohol 1 2015
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 27, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 27, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00